Stockscreener 앱 받기
384.02
0.26%
1.00
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’ - Benzinga
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
Third-quarter results are due before markets open Oct. 29; West Pharmaceutical's call follows at 8 a.m. - Stock Titan
West Pharmaceutical Services Needs Faster Earnings Growth To Justify Its Price (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short - Yahoo Finance
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
BDX Expands U.S. Manufacturing With $19B Healthcare Investment - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - Zacks Investment Research
West Pharmaceutical: Still A Buy, But Expectations Are Rising - Seeking Alpha
PCR Packaging For Pharma And Otc Market 7.2% CAGR to 2035 on ESG MandatesNews and Statistics - IndexBox
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal - TradingView
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - TradingView
Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services Highlights Leadership & Expertise - Contract Pharma
Is West Pharmaceutical Services Inc (WST) Overvalued After 3.2% - GuruFocus
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Reasons to Retain Doximity Stock in Your Portfolio for Now - Zacks Investment Research
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report - Yahoo Finance
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report - inkl
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide - PR Newswire
Patient choice and drug-development risks are on the agenda for West's Milan talks - Stock Titan
A director receives 44 units payable in shares at West Pharmaceutical (WST), bringing her balance to 350.87. - Stock Titan
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Stock Forecast & Analyst Predictions - Simply Wall Street
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical Services stock reports 13.80 percent revenue growth - AD HOC NEWS
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research
West Pharmaceutical Services stock attracts analyst coverage - AD HOC NEWS
West Pharmaceutical stock enters earnings watch with USD 382.00 target - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
What Comes Next for West Pharmaceutical Services (NYSE:WST)? - kalkinemedia.com
West Pharmaceutical Services stock gains after target rises - ad-hoc-news.de
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing - Zacks Investment Research
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says - marketscreener.com
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says - Yahoo Finance
West Pharmaceutical Services stock holds near its yearly range - AD HOC NEWS
Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 - Yahoo Finance
1.67%
자본화:
|
볼륨(24시간):